Blog Read the latest perspectives from our team of subject matter experts and others Unlocking Smarter Clinical Trial Feasibility with Connected DataWhen it comes to clinical trial feasibility, the stakes are high. Choosing the wrong sites or drafting a protocol without full visibility into patient populations can lead to costly… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Drug Development Global Impact KOL Engagement Patient Representation Provider Data Post Industries:Digital Health Health Plans Pharmaceutical & Biotechnology Drug DevelopmentPatient RepresentationOptimizing Clinical Data Registries: Opportunities for Inclusion and FeasibilityIn an October 2023 report, BMC Medicine completed a follow-up on a 10-year effort to understand, report on and track data sharing challenges with big pharma, specifically for clinical… Continue reading → Read the articleno Artificial IntelligenceEvaluating an AI Product in Life SciencesThe life sciences industry, characterized by stringent regulations, vast data sets, and the critical nature of its decisions, is increasingly turning to Artificial Intelligence (AI) for solutions. AI has the… Continue reading → Read the articleno KOL EngagementCompliant Science: The Critical Role of Compliance for Medical AffairsIn medical affairs, building and managing relationships with key opinion leaders (KOLs) is a critical component of successful product launches and long-term growth. But in today’s highly regulated environment,… Continue reading → Read the articleno KOL EngagementBoost HCP Access with a Unified Healthcare Data PlatformIn an August 2022 market research study conducted by H1 and the Medical Science Liaison Society (MSLS), more than 600 MSLs surveyed weighed in on their experiences and preferences… Continue reading → Read the articleno Artificial IntelligenceDrug Development4 AI predictions for the Life Sciences Sector by 2025The application of AI in the life sciences sector has the potential to revolutionize many aspects of research, development, and patient care. By 2025, we can anticipate pretty significant shifts… Continue reading → Read the articleno KOL EngagementKOL to Go? The Modern MSL & Mobile AppsAs the pharmaceutical industry becomes increasingly competitive, speed and efficiency are crucial for getting drugs to market faster. This is where mobile apps come in. And at the heart of… Continue reading → Read the articleno‹1234567›»
